Show simple item record

dc.contributor.authorB. Banzett, Roberten_US
dc.contributor.authorAdams, Lewisen_US
dc.contributor.authorR. O'Donnell, Carlen_US
dc.contributor.authorA. Gilman, Seanen_US
dc.contributor.authorW. Lansing, Roberten_US
dc.contributor.authorM. Schwartzstein, Richarden_US
dc.date.accessioned2017-04-24T10:18:35Z
dc.date.available2017-04-24T10:18:35Z
dc.date.issued2011en_US
dc.date.modified2012-03-09T05:28:32Z
dc.identifier.issn1073449Xen_US
dc.identifier.doi10.1164/rccm.201101-0005OCen_US
dc.identifier.urihttp://hdl.handle.net/10072/43492
dc.description.abstractRationale: Opioids are commonly used to relieve dyspnea, but clinical data are mixed and practice varies widely. Objectives: Evaluate the effect of morphine on dyspnea and ventilatory drive under well-controlled laboratory conditions. Methods: Six healthy volunteers received morphine (0.07 mg/kg) and placebo intravenously on separate days (randomized, blinded). We measured two responses to a CO2 stimulus: (1) perceptual response (breathing discomfort; described by subjects as "air hunger") induced by increasing partial pressure of end-tidal carbon dioxide (PetCO2) during restricted ventilation, measured with a visual analog scale (range, "neutral" to "intolerable"); and (2) ventilatory response, measured in separate trials during unrestricted breathing. Measurements and Main Results: We determined the PetCO2 that produced a 60% breathing discomfort rating in each subject before morphine (median, 8.5 mm Hg above resting PetCO2). At the same PetCO2 after morphine administration, median breathing discomfort was reduced by 65% of its pretreatment value; P < 0.001. Ventilation fell 28% at the same PetCO2; P < 0.01. The effect of morphine on breathing discomfort was not significantly correlated with the effect on ventilatory response. Placebo had no effect. Conclusions: (1) A moderate morphine dose produced substantial relief of laboratory dyspnea, with a smaller reduction of ventilation. (2) In contrast to an earlier laboratory model of breathing effort, this laboratory model of air hunger established a highly significant treatment effect consistent in magnitude with clinical studies of opioids. Laboratory studies require fewer subjects and enable physiological measurements that are difficult to make in a clinical setting. Within-subject comparison of the response to carefully controlled laboratory stimuli can be an efficient means to optimize treatments before clinical trials.en_US
dc.description.peerreviewedYesen_US
dc.description.publicationstatusYesen_US
dc.languageEnglishen_US
dc.publisherAmerican Thoracic Societyen_US
dc.publisher.placeUnited Statesen_US
dc.relation.ispartofstudentpublicationNen_US
dc.relation.ispartofpagefrom920en_US
dc.relation.ispartofpageto927en_US
dc.relation.ispartofissue8en_US
dc.relation.ispartofjournalAmerican Journal of Respiratory and Critical Care Medicineen_US
dc.relation.ispartofvolume184en_US
dc.rights.retentionYen_US
dc.subject.fieldofresearchRespiratory Diseasesen_US
dc.subject.fieldofresearchcode110203en_US
dc.titleUsing Laboratory Models to Test Treatment: Morphine Reduces Dyspnea and Hypercapnic Ventilatory Responseen_US
dc.typeJournal articleen_US
dc.type.descriptionC1 - Peer Reviewed (HERDC)en_US
dc.type.codeC - Journal Articlesen_US
gro.rights.copyrightSelf-archiving of the author-manuscript version is not yet supported by this journal. Please refer to the journal link for access to the definitive, published version or contact the authors for more information.en_US
gro.date.issued2011
gro.hasfulltextNo Full Text


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record